Peripheral Nerve Stimulator Market is an alternative pain control option for those who have problems in taking oral medication
Verfasser: yogesh on Wednesday, 3 April 2019Close to 600 neurological disorders affect approximately 500 million American every year, as per the National Institute of Neurological Disorders and Stroke.
Growing incidences of nerve injuries and increase in obese population causing neurodegenerative disorders are two critical factors driving the demand for peripheral nerve stimulators.
Demand for peripheral nerve stimulators is expected to grow further given the high applicability through anesthesia procedures and in severe neuropathic pain.
Peripheral nerve stimulators being a targeted pain relief treatment allowing patients to take fewer pain medications indicates promising opportunities in the near future, specifically associated with pain management technologies.
Germany, U.S., Switzerland, Sweden, and Canada remain the top importers of peripheral nerve stimulator materials.
With the Food and Drug Administration (FDA) recently clearing two neurostimulation devices- SPRINT endura and extensa, for treating acute and chronic pain, the future landscape for peripheral nerve stimulators (PNS) looks promising. As per a recently released in-depth study by Persistence Market Research (PMR), the global peripheral nerve stimulator market is projected to represent a robust year on year revenue growth of approximately 6.9 percent in 2019. The global peripheral nerve stimulator market is expected to reach a valuation of US$ 375.9 Million, during the same period.